ProKidney Corp (NASDAQ: PROK) is -41.41% lower on its value in year-to-date trading and has touched a low of $0.46 and a high of $4.44 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The PROK stock was last observed hovering at around $0.91 in the last trading session, with the day’s gains setting it 0.08%.
Currently trading at $0.99, the stock is 30.64% and -2.63% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.18 million and changing 8.80% at the moment leaves the stock -42.56% off its SMA200. PROK registered -63.60% loss for a year compared to 6-month loss of -47.05%. The firm has a 50-day simple moving average (SMA 50) of $1.01702 and a 200-day simple moving average (SMA200) of $1.72388.
The stock witnessed a -1.96% gain in the last 1 month and extending the period to 3 months gives it a -41.75%, and is 24.41% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 19.96% over the week and 22.98% over the month.
ProKidney Corp (PROK) has around 204 employees, a market worth around $289.83M and $0.08M in sales. Profit margin for the company is -80507.89%. Distance from 52-week low is 115.12% and -77.70% from its 52-week high.
The EPS is expected to grow by 3.70% this year, but quarterly earnings will post -100.00% year-over-year. Quarterly sales are estimated to shrink 0.00% in year-over-year returns.
107.0 institutions hold shares in ProKidney Corp (PROK), with institutional investors hold 63.14% of the company’s shares. The shares outstanding are 128.05M, and float is at 92.44M with Short Float at 12.90%. Institutions hold 44.35% of the Float.
The top institutional shareholder in the company is SUVRETTA CAPITAL MANAGEMENT, LLC with over 9.34 million shares valued at $22.98 million. The investor’s holdings represent 12.306 of the PROK Shares outstanding. As of 2024-06-30, the second largest holder is VANGUARD GROUP INC with 3.98 million shares valued at $9.78 million to account for 5.237 of the shares outstanding. The other top investors are BLACKROCK INC. which holds 3.66 million shares representing 4.8167 and valued at over $8.99 million, while BLEICHROEDER LP holds 3.4417 of the shares totaling 2.61 million with a market value of $6.43 million.
ProKidney Corp (PROK) Insider Activity
The most recent transaction is an insider purchase by Control Empresarial de Capital, the company’s Add’l Rep. Persons-see Ex.99-1. SEC filings show that Control Empresarial de Capital bought 387,393 shares of the company’s common stock on Apr 22 ’25 at a price of $0.71 per share for a total of $0.28 million. Following the purchase, the insider now owns 73.84 million shares.
ProKidney Corp disclosed in a document filed with the SEC on Apr 17 ’25 that Control Empresarial de Capital (Add’l Rep. Persons-see Ex.99-1) bought a total of 25,000 shares of the company’s common stock. The trade occurred on Apr 17 ’25 and was made at $0.75 per share for $18690.0. Following the transaction, the insider now directly holds 73.46 million shares of the PROK stock.
Still, SEC filings show that on Apr 16 ’25, Control Empresarial de Capital (Add’l Rep. Persons-see Ex.99-1) acquired 100,000 shares at an average price of $0.75 for $74820.0. The insider now directly holds 73,430,330 shares of ProKidney Corp (PROK).
